S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer
Status:
Completed
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
This was a randomised, multicenter, phase 3 trial. Patients who were age of 70 years or older
with histologically confirmed esophageal cancer were randomly assigned to S-1 concurrent with
radiotherapy or radiotherapy alone.The primary endpoint was overall survival.